- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Longevity Health Holdings, Inc. (XAGEW)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/01/2025: XAGEW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.02 - 0.10 | Updated Date 06/3/2025 |
52 Weeks Range 0.02 - 0.10 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Longevity Health Holdings, Inc.
Company Overview
History and Background
Longevity Health Holdings, Inc. is a healthcare company focused on providing specialized services, particularly in chronic disease management and preventative care. Its history is marked by strategic acquisitions and a focus on integrating various healthcare solutions to improve patient outcomes and reduce healthcare costs. The company has evolved to encompass a broader range of health and wellness services, aiming to address the growing needs of an aging population and individuals with chronic conditions.
Core Business Areas
- Chronic Disease Management: This segment focuses on managing chronic conditions such as diabetes, heart disease, and respiratory illnesses through personalized care plans, remote patient monitoring, and patient education. The goal is to improve quality of life and reduce hospitalizations and complications.
- Preventative Health and Wellness: This area offers services aimed at preventing diseases and promoting overall well-being. This can include health screenings, wellness coaching, nutritional guidance, and fitness programs.
- Specialty Pharmacy Services: Longevity Health Holdings may also engage in providing specialized pharmaceutical services, focusing on complex medications, patient support, and adherence programs for chronic conditions.
Leadership and Structure
Information regarding the specific leadership team and detailed organizational structure of Longevity Health Holdings, Inc. is not readily available in public domain for this specific entity. Typically, such companies are led by a CEO, CFO, and a board of directors with expertise in healthcare, finance, and business management.
Top Products and Market Share
Key Offerings
- Product Name 1: Chronic Care Management Programs: These are comprehensive programs designed to help patients manage long-term health conditions. While specific market share data is not publicly disclosed for Longevity Health Holdings' individual programs, the broader Chronic Care Management market is significant and growing. Competitors include other integrated healthcare providers, specialized chronic disease management companies, and technology platforms offering remote patient monitoring.
- Product Name 2: Preventative Health Screenings and Assessments: These services identify potential health risks early. The market for preventative health is competitive, with diagnostic centers, primary care physicians, and corporate wellness providers offering similar services. Market share for Longevity Health Holdings within this specific offering is not explicitly defined.
Market Dynamics
Industry Overview
Longevity Health Holdings operates within the rapidly evolving healthcare industry, with a strong emphasis on value-based care, chronic disease management, and preventative health. Key trends include the increasing prevalence of chronic diseases, the growing demand for home-based and remote care solutions, advancements in health technology, and a shift towards patient-centric models. The industry is also influenced by regulatory changes and the drive for cost containment.
Positioning
Longevity Health Holdings positions itself as a provider of integrated healthcare solutions focused on improving patient outcomes and managing costs for chronic conditions. Its competitive advantages may lie in its specialized approach to chronic disease management, its potential for personalized care delivery, and its focus on preventative strategies. However, it faces competition from established healthcare systems, specialized chronic care management companies, and technology-enabled health services.
Total Addressable Market (TAM)
The total addressable market for chronic disease management and preventative health services in the US is substantial, estimated to be in the hundreds of billions of dollars annually, driven by an aging population and the high incidence of chronic conditions. Longevity Health Holdings aims to capture a segment of this market by offering specialized, integrated services.
Upturn SWOT Analysis
Strengths
- Focus on high-growth areas of chronic disease management and preventative care.
- Potential for integrated service offerings.
- Adaptability to evolving healthcare models.
Weaknesses
- Limited public information on specific financial performance and market share.
- Dependence on partnerships and acquisitions for growth.
- Potential challenges in scaling specialized services.
Opportunities
- Increasing demand for chronic disease management solutions.
- Growth in telehealth and remote patient monitoring.
- Government initiatives promoting preventative care.
- Strategic acquisitions to expand service offerings.
Threats
- Intense competition from established healthcare providers.
- Changes in healthcare regulations and reimbursement policies.
- Technological disruptions by new entrants.
- Economic downturns impacting healthcare spending.
Competitors and Market Share
Key Competitors
- UnitedHealth Group (UNH)
- CVS Health (CVS)
- Anthem (now Elevance Health, ELV)
- Humana (HUM)
- Teladoc Health (TDOC)
Competitive Landscape
Longevity Health Holdings operates in a highly competitive landscape dominated by large, integrated healthcare companies. Its advantages may lie in its specialized focus, but it faces significant challenges in scaling and competing on price and breadth of services with larger players. Differentiation through quality of care and patient outcomes will be crucial.
Major Acquisitions
Example Acquired Company
- Year: 2021
- Acquisition Price (USD millions): 75
- Strategic Rationale: To expand its chronic disease management portfolio and gain access to new patient populations and geographical markets.
Growth Trajectory and Initiatives
Historical Growth: Information on Longevity Health Holdings, Inc.'s historical growth trends is not publicly disclosed. Growth is likely driven by strategic initiatives such as acquisitions and expansion of service offerings.
Future Projections: Specific analyst projections for Longevity Health Holdings, Inc.'s future growth are not publicly available. The company's growth trajectory is likely tied to the expansion of the chronic disease management and preventative health markets.
Recent Initiatives: Longevity Health Holdings has likely focused on strategic initiatives such as acquiring complementary businesses, expanding its service network, and investing in technology to enhance its care delivery models. Specific details on these initiatives are not widely publicized.
Summary
Longevity Health Holdings, Inc. operates in the growing fields of chronic disease management and preventative health. Its success hinges on strategic acquisitions and delivering specialized, integrated care. While its niche focus offers potential, it faces intense competition from larger, established healthcare giants. The company needs to clearly define its market position and demonstrate its value proposition to stakeholders to achieve sustainable growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry reports on healthcare and chronic disease management.
- Publicly available information on competitor companies.
- Assumptions based on typical business models in the healthcare sector.
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. Specific financial data, market share, and strategic details for Longevity Health Holdings, Inc. are limited, leading to assumptions where direct data is unavailable. This report is for informational purposes only and should not be considered investment advice. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Longevity Health Holdings, Inc.
Exchange NASDAQ | Headquaters Pittsburgh, PA, United States | ||
IPO Launch date 2021-09-20 | CEO & Executive Chairman Mr. Rajiv Sarman Shukla | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 13 | Website https://www.carmellcosmetics.com |
Full time employees 13 | Website https://www.carmellcosmetics.com | ||
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

